Home Cyclica And Dalton Announce Collaboration Agreement To Identify And Develop New Drug Candidates
 

Keywords :   


Cyclica And Dalton Announce Collaboration Agreement To Identify And Develop New Drug Candidates

2013-04-12 09:19:56| drugdiscoveryonline News Articles

Jason Mitakidis, President and CEO of Cyclica, Peter Pekos, President and CEO of Dalton Pharma Services and Dr. Judd Berman, Co-Founder of Dalton Medicinal Chemistry today announced a collaboration for the joint identification and development of a number of new drug candidates

Tags: agreement develop drug identify

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05'I had no choice but to get a 35-year mortgage'
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Businessman Tony O'Reilly dies after short illness
18.05Eastern North Pacific Tropical Weather Outlook
More »